The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Poster Presentation(E) Pharmaceutical Health Care and Sciences

[29-52-pm1]Clinical Pharmacy 27, Pharmacotherapies (Cancer)

Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 52 (B305, Bldg. 1, Area 2 [3F])
Discusser: Shinsuke Akagi, Chigusa Kikuchi

[29-52-pm1-01]Detection of the Sites of Action of Sotorasib in the Rat Gastrointestinal Tract Using Immunohistochemistry

○Tetsuya Saita1, Miyabi Teramoto1, Miyu Tsuzuki1 (1. Depart. Life Sci., Sojo Univ.)

[29-52-pm1-02S]Impact of concomitant proton pump inhibitors on immune-related adverse events and efficacy in patients receiving pembrolizumab monotherapy

○Yihan Sun1, Kenji Ikemura2, Masahiro Okuda2 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Osaka Univ. Hosp.)

[29-52-pm1-03S]Biomarker for atezolizumab/ bevacizumab combination and lenvatinib therapy in patients with HCC

○Yuina Koike1, Yuka Kyoso1, Kunihide Mori2,3, Yasuaki Tatsumi1, Hidenari Nagai2,3, Koji Higai1 (1. Sch. Pharm. Sci.,Toho Univ., 2. Dept. of Internal Medicine (Omori), Toho Univ., 3. Div. of Gastroenterology and Hepat., Tokyo Kamata Medical Center)

[29-52-pm1-04S]Imuno-modulating effects by low-dose doxorubicin in pancreas cells

○Nozomi Takada1, Kunihide Mori1,2, Yasuaki Tatsumi1, Hidenari Nagai2,3, Koji Higai1 (1. Faculty of Pharmaceutical Sciences, Toho University, 2. Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), School of Medicine, Faculty of Medicine, Toho University, 3. Division of Gastroenterology and Hepatology, Tokyo Kamata Medical Center)

[29-52-pm1-05S]The impact of proton pump inhibitors on prognosis and adverse events of osimertinib in patients with non-small cell lung cancer

○Sachiho Harada1, Miki Sato1,2, Ryo Manabe3, Sojiro Kusumoto3, Saeko kashimura4, Masayuki Ohbayashi1,2, Noriko Kohyama1,2, Akihiko Tanaka3, Mari Kogo1,2 (1. Showa Med. Univ. Sch. Pharm., 2. Showa Univ. Grad. Sch. Pharm., 3. Division of Respiratory Medicine and Allergology, Showa Med. Univ. Hospital, 4. Pharm, Showa Med. Univ. Koto Toyosu Hospital)

[29-52-pm1-06]Development of PEG-linked BiTE antibodies composed of cyclic scFvs and evaluation of their antitumor activity in tumor models

○Sena Kamesawa1, Masaya Katou1, Taturou Aramaki2, Koushirou Doi2, Takako Nagata1, Yoshiki Funakoshi2, Sayo Shiranita2, Takuya Tanoue2, Prin Sungwan3, Yoshihiro Kobashigawa1, Takashi Satou1, Seiji Okada3, Hiroshi Morioka1 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Fac. Pharm. Sci., Kumamoto Univ., 3. Joint Res. Ctr. for Human Retrovirus Infection, Kumamoto Univ.)

[29-52-pm1-07S]Clinical Impact of Neutropenia Induced by Trifluridine/Tipiracil (TAS-102) Chemotherapy

○Seiya Kotani1, Yukio Kadokawa2, Mari Takagi2, Akitoshi Tatsumi1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. Department of Pharmacy, Osaka International Cancer Institute)

[29-52-pm1-08S]Examination of peripheral neuropathy caused by cold compresses on skin Injury in a mouse model of oxaliplatin extravasation

○Rin Kawanami1, Saki Ichinohe1, Kazuki Aida1, Tomiyuki Sugi1, Reiko Ishii-Nozawa1 (1. Meiji Pharmaceut. Univ.)

[29-52-pm1-09S]Analsis of the mechanism of the autophagy inhibitory effect of arctigenin,the main component from Arctium lappa.

○Naoki Ando1, Yuka Maeda1, Shinya Okubo1,2, Shigeru Oiso1,2 (1. Dept. Pharm. Fac. Pharm. Sci., Nagasaki international Univ., 2. Grad. Sci., Nagasaki international Univ.)

[29-52-pm1-10S]Analysis of the cell senescence-inducing effect of cigarette extract

○Kenshin Yamamoto1, Ayumu Shibata1, Yuriko Hishida1, Shigehiro Osada1, Tomoaki Hishida1 (1. Wakayama Medical University.Pharm)
Back to Category List